ArticleESMO real world data and digital oncology2026

Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO group.

A Rametta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.